Weijia Liao
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Hepatology top 2%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Yan LiaoSongqing HeJunfei JinYing OuLiling QinShengguang YuanJian HuangLai Wei
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (26 papers)Inflammatory Biomarkers in Disease Prognosis (13 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports
- Partner nations
- ChinaUnited StatesOman
In The Last Decade
Weijia Liao
62 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 663
- Cancer Research 445
- Oncology 360
- Hepatology 328
- Pulmonary and Respiratory Medicine 232
Countries citing papers authored by Weijia Liao
This map shows the geographic impact of Weijia Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijia Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijia Liao more than expected).
Fields of papers citing papers by Weijia Liao
This network shows the impact of papers produced by Weijia Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijia Liao. The network helps show where Weijia Liao may publish in the future.
Co-authorship network of co-authors of Weijia Liao
This figure shows the co-authorship network connecting the top 25 collaborators of Weijia Liao. A scholar is included among the top collaborators of Weijia Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijia Liao. Weijia Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 11 | |
| 4 | 20 | |
| 5 | 13 | |
| 6 | 8 | |
| 7 | 20 | |
| 8 | 7 | |
| 9 | 11 | |
| 10 | 5 | |
| 11 | 4 | |
| 12 | 19 | |
| 13 | 39 | |
| 14 | 2 | |
| 15 | 14 | |
| 16 | 13 | |
| 17 | 39 | |
| 18 | 25 | |
| 19 | 36 | |
| 20 | [Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma]. | 5 |
About Weijia Liao
Weijia Liao is a scholar working on Hepatology, Cancer Research and Oncology, having authored 64 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Inflammatory Biomarkers in Disease Prognosis (13 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). The work is most often cited by research in Hepatology (328 citations), Cancer Research (445 citations) and Oncology (360 citations). Weijia Liao has collaborated with scholars based in China, United States and Oman. Frequent co-authors include Yan Liao, Songqing He, Junfei Jin, Ying Ou, Liling Qin, Shengguang Yuan, Jian Huang, Lai Wei, Peng‐Peng Zhu and Xing Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.